Late-onset Pompe disease: preliminary results of enzyme replacement therapy
Pompe disease is an orphan hereditary accumulation disease associated with a deficiency of the lysosomal enzyme alglucosidase alpha. Manifestations of the disease are associated with pathological deposition of glycogen in body tissues as a result of GAA gene mutation and subsequent reduction in the...
Saved in:
| Main Authors: | L. P. Smertina, F. I. Ausheva, A. V. Gryaznov, D. A. Svetlakov, L. N. Kolbasin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2019-07-01
|
| Series: | Нервно-мышечные болезни |
| Subjects: | |
| Online Access: | https://nmb.abvpress.ru/jour/article/view/326 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Five-Year Outcomes of Patients with Pompe Disease Identified by the Pennsylvania Newborn Screen
by: Hayley A. Ron, et al.
Published: (2025-02-01) -
Successful desensitization protocol to alglucosidase and avalglucosidase alfa in a patient with infantile-onset Pompe disease
by: Miriam Gendive, et al.
Published: (2025-06-01) -
Case Report: Incidental late-onset Pompe disease diagnosis in a man with no clinical and instrumental evidence of neuromuscular dysfunction
by: Monica Sciacco, et al.
Published: (2025-06-01) -
Successful pregnancy outcome in patient with Pompe disease despite discontinuation of enzyme replacement therapy
by: Dunja Leskovar Lemešić, et al.
Published: (2025-05-01) -
Late-onset Pompe disease with phenotype of the limb-girdle muscular dystrophy
by: S. A. Kurbatov, et al.
Published: (2015-09-01)